49
NPS Score
VS
Intellia Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 12
- TOTAL
RATINGS
Spark Therapeutics
- EMPLOYEE
PARTICIPANTS - 14
- TOTAL
RATINGS
Intellia Therapeutics vs Spark Therapeutics
Compare Intellia Therapeutics versus Spark Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 12 employees and customers of Intellia Therapeutics and 14 employees and customers of Spark Therapeutics.
Intellia Therapeutics
Intellia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intellia Therapeutics. Their current market cap is $5.42B.
Spark Therapeutics
Spark Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Spark Therapeutics. Their current market cap is $4.29B.
3.5/5
Product Quality
3.7/5
3.3/5
Pricing
5/5
3.9/5
Customer Service
5/5
| 66% | Promoters |
|---|---|
| 17% | Passive |
| 17% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 51
See how Intellia Therapeutics compares to its competitors
See how Spark Therapeutics compares to its competitors
Working at Intellia Therapeutics vs Working at Spark Therapeutics
86 / 100
CEO Rating
Winner by 18%
68 / 100
CEO Rating
Intellia Therapeutics
Intellia Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Spark Therapeutics
Employees at Spark Therapeutics rate their CEO, Jeffrey Marrazzo, 68/100. This score is 18% lower than the scores of Intellia Therapeutics' CEO, John Leonard.